Journal:
:iranian red crescent medical journal
0
zhi-qin wu department of ophthalmology, renmin hospital of wuhan university, wuhan, hubei, china
yi-qiao xing department of ophthalmology, renmin hospital of wuhan university, wuhan, hubei, china; department of ophthalmology, renmin hospital of wuhan university, hubei, china. tel: +86-18107168013, fax: +86-7168657281
yan-ning yang department of ophthalmology, renmin hospital of wuhan university, wuhan, hubei, china
jing yuan department of ophthalmology, renmin hospital of wuhan university, wuhan, hubei, china
shang-wu nie department of ophthalmology, jinzhou central hospital, jinzhou, hubei, china
conclusions il-33 may be a potential new agent to attenuate rir injury by reducing inflammatory cell infiltration and preventing apoptosis. results our data revealed that il-33 pretreatment maintained a better retinal structure, inhibited leukocyte infiltration (il-33 vs. mg with p < 0.01 and il-33 vs. pbs group with p < 0.01), and reduced the apoptosis of retinal ganglion cells (il-33 vs. mg w...